Cargando…
Use of oral rivaroxaban in cerebral venous thrombosis
BACKGROUND: Cerebral venous thrombosis (CVT) is an uncommon cause of stroke in humans and the mainstay of treatment is anticoagulation unless contraindicated. Non-vitamin K oral anticoagulants have not been duly evaluated in randomized controlled trials in CVT. OBJECTIVE: To compare the efficacy and...
Autores principales: | Maqsood, Muhammad, Imran Hasan Khan, Muhammad, Yameen, Mubashar, Aziz Ahmed, Kashif, Hussain, Nazim, Hussain, Safdar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717856/ https://www.ncbi.nlm.nih.gov/pubmed/33391859 http://dx.doi.org/10.1080/21556660.2020.1838769 |
Ejemplares similares
-
The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis
por: Fayyaz, Muniba, et al.
Publicado: (2019) -
Rivaroxaban for the treatment of cerebral venous thrombosis
por: Esmaeili, Sara, et al.
Publicado: (2021) -
An Observational Study to Evaluate the Effectiveness of Rivaroxaban in the Management of Cerebral Venous Sinus Thrombosis
por: Fatima, Meraj, et al.
Publicado: (2021) -
Treatment Failure of Cerebral Venous Thrombosis With Rivaroxaban: A Case Report and Narrative Review
por: Mohamed, Mustafa, et al.
Publicado: (2022) -
Reversal of Bioprosthetic Aortic Valve Thrombosis Using Rivaroxaban—A Case Report
por: Sharma, Harish, et al.
Publicado: (2020)